2.0
25 Feb 2026
Recommend
CEO approval
Business outlook
Pros
One great product People are great
Cons
Executive team does not have clear strategy. Consistently under capitalized. Can't afford to develop products effectively. Stock options rarely offered and no path to profitability. Bonus payments are 2 years behind(!). Little prospects for career growth at Director and above. High performance is not rewarded. Medical plan was a strong benefit but was significantly reduced and costs to employees increased.